Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?
The dominant paradigm in cancer treatment is that cancer cells die from the common
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
[引用][C] Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and Clinical Data Tell Us?
JM Brown, G Wilson - Cancer Biology & Therapy, 2003 - cir.nii.ac.jp
Apoptosis Genes and Resistance to Cancer Therapy: What Does the Experimental and
Clinical Data Tell Us? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] …
Clinical Data Tell Us? | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] …
Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?
JM Brown, G Wilson - Cancer biology & therapy, 2003 - pubmed.ncbi.nlm.nih.gov
The dominant paradigm in cancer treatment is that cancer cells die from the common
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?
JM Brown, G Wilson - Cancer Biology & Therapy, 2003 - europepmc.org
The dominant paradigm in cancer treatment is that cancer cells die from the common
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
[PDF][PDF] Apoptosis Genes and Resistance to Cancer Therapy
M Brown, G Wilson - Cancer Biology & Therapy, 2003 - researchgate.net
The dominant paradigm in cancer treatment is that cancer cells die from the common
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …
pathway of apoptosis subsequent to DNA damage by anticancer agents and that cells …